In the long run this is going to be a really good stock to have gotten into imo. Just look at the portfolio, so many opportunities within the company itself. I know, not all will pan out, but it is almost like an ETF of early stage drug opportunities, hitting the market with several and on the cusp with many. They all seem to make business sense too (the market is thought out) besides being technical wonders. And the pipeline just continues to increase. A couple to several years and I think we will all be very happy
News 
Market Data 
Discover 
